Profile data is unavailable for this security.
About the company
Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals Inc., is a pharmaceutical research and development (R&D) company. The Company is engaged in developing and patenting a polymer delivery system, Invisicare, and formulating over forty topical skin products. Its flagship product, Pivotal, is a patented polymer delivery system technology, Invisicare. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. Invisicare is specifically formulated to carry water-insoluble active and certain cationic active ingredients in water-based products without the use of alcohol, silicones, waxes, or other organic solvents. It is also exploring opportunities in medical markets outside the dermatology market.
- Revenue in USD (TTM)20.00k
- Net income in USD-1.16m
- Incorporated1998
- Employees2.00
- LocationSkinvisible Inc6320 S SANDHILL ROAD, UNIT 9LAS VEGAS 89120United StatesUSA
- Phone+1 (702) 433-7154
- Fax+1 (702) 433-7192
- Websitehttp://www.skinvisible.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Skinvisible Inc | 20.00k | -1.16m | 953.37k | 2.00 | -- | -- | -- | 47.67 | -0.255 | -0.255 | 0.0044 | -2.05 | 0.1113 | -- | 0.6373 | 10,000.00 | -644.52 | -747.32 | -- | -- | 100.00 | 98.00 | -5,788.80 | -611.01 | -- | -0.7226 | -- | -- | -92.84 | -22.02 | -94.50 | -- | -4.11 | -- |
| Megola Inc | 0.00 | 0.00 | 1.40m | 5.00 | -- | 0.1126 | -- | -- | 0.00 | 0.00 | 0.00 | 0.0427 | 0.00 | -- | -- | -- | 0.00 | -26.73 | 0.00 | -32.61 | -- | -- | -- | -200.57 | -- | -- | 0.00 | -- | -- | -- | -100.00 | -- | -- | -- |
| Toughbuilt Industries Inc | 89.62m | -51.31m | 1.73m | 259.00 | -- | 0.2094 | -- | 0.0193 | -203.00 | -203.00 | 310.56 | 14.57 | 1.14 | 1.94 | 5.53 | 346,033.30 | -65.18 | -74.66 | -158.32 | -170.50 | 26.39 | 27.44 | -57.25 | -52.75 | 0.2135 | -- | 0.0788 | -- | 36.03 | 46.32 | -24.61 | -- | 135.82 | -- |
| Mace Security International Inc | 6.29m | -4.42m | 3.37m | 164.00 | -- | 1.24 | -- | 0.5365 | -0.0674 | -0.0674 | 0.0959 | 0.0413 | 0.7129 | 1.20 | 7.46 | -- | -50.14 | -10.95 | -71.09 | -13.60 | 28.41 | 37.09 | -70.33 | -10.18 | 0.432 | -10.57 | 0.4126 | -- | -24.70 | -10.51 | -154.95 | -- | -26.11 | -- |
| Navco Pharmaceuticals Inc | 0.00 | -1.66m | 4.17m | -- | -- | -- | -- | -- | -0.4714 | -0.4714 | 0.00 | -0.0046 | 0.00 | -- | -- | -- | -648.75 | -- | -- | -- | -- | -- | -- | -- | 0.5617 | -259.08 | -- | -- | -- | -- | -- | -- | -- | -- |
| Bemax Inc | 80.52k | -199.53k | 4.75m | -- | -- | -- | -- | 58.93 | -205.10 | -205.10 | 1.18 | -1.16 | 0.5306 | -- | -- | -- | -131.49 | -228.89 | -- | -- | 2.67 | -45.89 | -247.80 | -511.34 | 0.2641 | -10.18 | -- | -- | -2.04 | -35.98 | -60.90 | -- | -- | -- |
